Subcutaneous injections of RELISTOR at 150/ 100 mg/ kg/ day to rats resulted in decreased offspring weights; doses up to 25 mg/ kg/ day (18 times the exposure [AUC] in humans at a subcutaneous dose of 0.3 mg/ kg) had no effect on labour, delivery, or offspring survival and growth.